0001171843-12-002830.txt : 20120731 0001171843-12-002830.hdr.sgml : 20120731 20120731161029 ACCESSION NUMBER: 0001171843-12-002830 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120726 ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant FILED AS OF DATE: 20120731 DATE AS OF CHANGE: 20120731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMYRIS, INC. CENTRAL INDEX KEY: 0001365916 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34885 FILM NUMBER: 12996999 BUSINESS ADDRESS: STREET 1: 5885 HOLLIS ST SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-0761 MAIL ADDRESS: STREET 1: 5885 HOLLIS ST SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC DATE OF NAME CHANGE: 20060613 8-K 1 f8k_073112.htm FORM 8-K f8k_073112.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
____________________________
 
FORM 8-K
 
Current Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

July 26, 2012
Date of report (Date of earliest event reported)
 
Amyris, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
  
001-34885
  
55-0856151
(State or other jurisdiction
of incorporation)
  
(Commission File Number)
  
(I.R.S. Employer
Identification No.)
 
5885 Hollis Street, Suite 100, Emeryville, CA 94608
(Address of principal executive offices) (Zip Code)
 
(510) 450-0761
(Registrant’s telephone number, including area code)
 
_____________________________________________
(Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):
 
 
o                                    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o                                    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o                                    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o                                    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
Item 2.03
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of Registrant.

This Current Report on Form 8-K is being filed by Amyris, Inc. (the “Company”) to disclose funding under loan agreements previously disclosed in the Company’s Current Report on Form 8-K filed on July 19, 2012.  As background, as of July 13, 2012, Amyris Brasil Ltda. (“AB”), a Brazilian subsidiary of the registrant, Amyris, Inc. (the “Company”), entered into a Note of Bank Credit with each of Banco Pine S.A. (“Pine”) and Nossa Caixa Desenvolvimento, the Sao Paulo State development bank (“Nossa Caixa” and, together with Pine, the “Lenders”) and a Fiduciary Conveyance of Movable Goods agreement among AB and both Lenders (such agreements and instruments, collectively, the “Loan Agreements”).

On July 26, 2012, AB received an aggregate of R$52 million (approximately US$25.7 million based on the exchange rate as of July 26, 2012) (R$22 million from Pine and R$30 million from Nossa Caixa) in funding under the Loan Agreements entered into on July 13, 2012.  Such loans have a final maturity date of July 15, 2022 and bear a fixed interest rate of 5.5% per year.  For the first two years that the loans are outstanding, AB is required to pay interest only on a quarterly basis.  After August 15, 2014, AB is required to pay equal monthly installments of both principal and interest for the remainder of the term of the loans.
 
 
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
AMYRIS, INC.

Date:  July 31, 2012                                                                           By:  /s/ Gary Loeb
  Gary Loeb
  SVP and General Counsel